What is Tremelimumab?
CATEGORY:
Tremelimumab (formerly ticilimumab, CP-675,206) is an antibody that is in clinical trials for several different types of cancer.
Save up to 80% off your prescriptions!
How do members experience Tremelimumab?
Top 5 reported purposes & perceived effectiveness
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Adenocarcinoma (non-small cell lung cancer) | 1 | 0 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Fatigue | 1 |
Learn more about our community’s experience with Tremelimumab
What are people saying about Tremelimumab?
3
3
members have reported taking Tremelimumab
Join the conversation and connect with people who have taken Tremelimumab
Last updated: